vs

Side-by-side financial comparison of LTC PROPERTIES INC (LTC) and MEDIFAST INC (MED). Click either name above to swap in a different company.

LTC PROPERTIES INC is the larger business by last-quarter revenue ($84.3M vs $75.1M, roughly 1.1× MEDIFAST INC). On growth, LTC PROPERTIES INC posted the faster year-over-year revenue change (60.3% vs -36.9%). LTC PROPERTIES INC produced more free cash flow last quarter ($128.7M vs $-6.6M). Over the past eight quarters, LTC PROPERTIES INC's revenue compounded faster (28.1% CAGR vs -34.4%).

LTC Properties Inc is a U.S.-based real estate investment trust (REIT) that owns, finances, and manages seniors housing and healthcare-related real estate assets. Its core portfolio includes assisted living facilities, skilled nursing properties, memory care centers, and independent living communities for senior care and healthcare service operators.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

LTC vs MED — Head-to-Head

Bigger by revenue
LTC
LTC
1.1× larger
LTC
$84.3M
$75.1M
MED
Growing faster (revenue YoY)
LTC
LTC
+97.2% gap
LTC
60.3%
-36.9%
MED
More free cash flow
LTC
LTC
$135.3M more FCF
LTC
$128.7M
$-6.6M
MED
Faster 2-yr revenue CAGR
LTC
LTC
Annualised
LTC
28.1%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LTC
LTC
MED
MED
Revenue
$84.3M
$75.1M
Net Profit
$103.7M
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
123.0%
Revenue YoY
60.3%
-36.9%
Net Profit YoY
429.1%
EPS (diluted)
$2.19
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LTC
LTC
MED
MED
Q4 25
$84.3M
$75.1M
Q3 25
$69.3M
$89.4M
Q2 25
$60.2M
$105.6M
Q1 25
$49.0M
$115.7M
Q4 24
$52.6M
$119.0M
Q3 24
$55.8M
$140.2M
Q2 24
$50.1M
$168.6M
Q1 24
$51.4M
$174.7M
Net Profit
LTC
LTC
MED
MED
Q4 25
$103.7M
Q3 25
$-20.0M
$-2.3M
Q2 25
$15.1M
$2.5M
Q1 25
$20.7M
$-772.0K
Q4 24
$19.6M
Q3 24
$29.4M
$1.1M
Q2 24
$19.4M
$-8.2M
Q1 24
$24.2M
$8.3M
Gross Margin
LTC
LTC
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
LTC
LTC
MED
MED
Q4 25
-10.4%
Q3 25
71.9%
-4.6%
Q2 25
80.5%
-1.0%
Q1 25
37.8%
-1.1%
Q4 24
0.6%
Q3 24
95.5%
1.5%
Q2 24
38.0%
-4.7%
Q1 24
47.3%
4.5%
Net Margin
LTC
LTC
MED
MED
Q4 25
123.0%
Q3 25
-28.9%
-2.5%
Q2 25
25.1%
2.3%
Q1 25
42.2%
-0.7%
Q4 24
37.3%
Q3 24
52.6%
0.8%
Q2 24
38.6%
-4.8%
Q1 24
47.2%
4.8%
EPS (diluted)
LTC
LTC
MED
MED
Q4 25
$2.19
$-1.64
Q3 25
$-0.44
$-0.21
Q2 25
$0.32
$0.22
Q1 25
$0.45
$-0.07
Q4 24
$0.38
$0.08
Q3 24
$0.66
$0.10
Q2 24
$0.44
$-0.75
Q1 24
$0.56
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LTC
LTC
MED
MED
Cash + ST InvestmentsLiquidity on hand
$14.4M
$167.3M
Total DebtLower is stronger
$842.2M
Stockholders' EquityBook value
$1.1B
$198.9M
Total Assets
$2.1B
$248.0M
Debt / EquityLower = less leverage
0.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LTC
LTC
MED
MED
Q4 25
$14.4M
$167.3M
Q3 25
$17.9M
$173.5M
Q2 25
$7.6M
$162.7M
Q1 25
$23.3M
$164.6M
Q4 24
$9.4M
$162.3M
Q3 24
$35.0M
$170.0M
Q2 24
$6.2M
$163.5M
Q1 24
$9.0M
$156.4M
Total Debt
LTC
LTC
MED
MED
Q4 25
$842.2M
Q3 25
$944.5M
Q2 25
$696.5M
Q1 25
$682.2M
Q4 24
$684.6M
Q3 24
$785.3M
Q2 24
$861.0M
Q1 24
$860.2M
Stockholders' Equity
LTC
LTC
MED
MED
Q4 25
$1.1B
$198.9M
Q3 25
$957.9M
$214.7M
Q2 25
$957.5M
$216.0M
Q1 25
$961.9M
$211.0M
Q4 24
$960.6M
$210.1M
Q3 24
$947.8M
$207.3M
Q2 24
$889.1M
$205.3M
Q1 24
$886.2M
$211.0M
Total Assets
LTC
LTC
MED
MED
Q4 25
$2.1B
$248.0M
Q3 25
$2.0B
$268.2M
Q2 25
$1.8B
$269.3M
Q1 25
$1.8B
$280.0M
Q4 24
$1.8B
$284.2M
Q3 24
$1.9B
$291.2M
Q2 24
$1.9B
$293.5M
Q1 24
$1.8B
$302.8M
Debt / Equity
LTC
LTC
MED
MED
Q4 25
0.78×
Q3 25
0.99×
Q2 25
0.73×
Q1 25
0.71×
Q4 24
0.71×
Q3 24
0.83×
Q2 24
0.97×
Q1 24
0.97×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LTC
LTC
MED
MED
Operating Cash FlowLast quarter
$136.0M
$-5.3M
Free Cash FlowOCF − Capex
$128.7M
$-6.6M
FCF MarginFCF / Revenue
152.7%
-8.8%
Capex IntensityCapex / Revenue
8.6%
1.8%
Cash ConversionOCF / Net Profit
1.31×
TTM Free Cash FlowTrailing 4 quarters
$220.1M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LTC
LTC
MED
MED
Q4 25
$136.0M
$-5.3M
Q3 25
$38.4M
$12.1M
Q2 25
$30.0M
$-3.4M
Q1 25
$29.6M
$3.4M
Q4 24
$125.9M
$-4.9M
Q3 24
$34.0M
$9.1M
Q2 24
$37.0M
$13.1M
Q1 24
$21.1M
$7.3M
Free Cash Flow
LTC
LTC
MED
MED
Q4 25
$128.7M
$-6.6M
Q3 25
$34.3M
$10.8M
Q2 25
$28.9M
$-4.8M
Q1 25
$28.2M
$1.9M
Q4 24
$112.2M
$-7.2M
Q3 24
$27.7M
$7.7M
Q2 24
$34.7M
$11.1M
Q1 24
$19.7M
$5.4M
FCF Margin
LTC
LTC
MED
MED
Q4 25
152.7%
-8.8%
Q3 25
49.4%
12.0%
Q2 25
47.9%
-4.5%
Q1 25
57.6%
1.6%
Q4 24
213.4%
-6.1%
Q3 24
49.7%
5.5%
Q2 24
69.1%
6.6%
Q1 24
38.4%
3.1%
Capex Intensity
LTC
LTC
MED
MED
Q4 25
8.6%
1.8%
Q3 25
6.0%
1.5%
Q2 25
1.9%
1.3%
Q1 25
2.7%
1.3%
Q4 24
26.0%
1.9%
Q3 24
11.2%
1.0%
Q2 24
4.6%
1.1%
Q1 24
2.6%
1.1%
Cash Conversion
LTC
LTC
MED
MED
Q4 25
1.31×
Q3 25
Q2 25
1.99×
-1.36×
Q1 25
1.43×
Q4 24
6.43×
Q3 24
1.16×
8.04×
Q2 24
1.91×
Q1 24
0.87×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LTC
LTC

Seniors Housing Operating Portfolio Segment$72.1M86%
Other$12.2M14%

MED
MED

Segment breakdown not available.

Related Comparisons